WGCA
TEVA icon

Wolf Group Capital Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Wolf Group Capital Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-7,883
Closed -$316K – 97
2013
Q4 		$316K Buy
+7,883
New +$310K 0.25% 91

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return

Wolf Group Capital Advisors's TEVA Position: Q1 2014 in Review

Wolf Group Capital Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2014, closing a stake of 7,883 shares — an estimated $316K sold.

Wolf Group Capital Advisors first reported a position in TEVA in Q4 2013 and held it in 1 quarter. The position peaked at $316K in Q4 2013. 772 funds tracked by Wall St. Rank hold TEVA as of Q1 2014.

  • Wolf Group Capital Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2014 after selling out during the quarter.
  • Wolf Group Capital Advisors sold 7,883 Teva Pharmaceutical Industries Limited shares in Q1 2014, an estimated $316K.
  • Wolf Group Capital Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 1 quarter.
  • Wolf Group Capital Advisors's Teva Pharmaceutical Industries Limited position peaked at $316K in Q4 2013.
  • 772 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2014.

Based on Wolf Group Capital Advisors's 13F filing for Q1 2014, filed 29 Apr 2014.